Breaking News
The Criminality Buried In The Epstein Files Is Worse Than Anyone Thought,...
A Critical Review of Impacts of Greenhouse Gas Emissions on the U.S. Climate
The Great Reject is Upon Us! - #SolutionsWatch
Google is issuing a call to action:
Top Tech News
Drone-launching underwater drone hitches a ride on ship and sub hulls
Humanoid Robots Get "Brains" As Dual-Use Fears Mount
SpaceX Authorized to Increase High Speed Internet Download Speeds 5X Through 2026
Space AI is the Key to the Technological Singularity
Velocitor X-1 eVTOL could be beating the traffic in just a year
Starlink smasher? China claims world's best high-powered microwave weapon
Wood scraps turn 'useless' desert sand into concrete
Let's Do a Detailed Review of Zorin -- Is This Good for Ex-Windows Users?
The World's First Sodium-Ion Battery EV Is A Winter Range Monster
China's CATL 5C Battery Breakthrough will Make Most Combustion Engine Vehicles OBSOLETE
The Next Plandemic: 3,625 Biolabs, Nipah Virus Patents, and Self-Amplifying mRNA Injections
The global expansion of high-containment biolabs without oversight — increasingly engaged in Nipah virus research — combined with aggressive patent consolidation of Nipah's core glycoproteins and their integration into mRNA and self-amplifying mRNA (saRNA) injection platforms, represents a profound and escalating global biosecurity risk.
A recent study identified 3,625 Biosafety Level-3 and Level-4 laboratories worldwide:
• 73% do not publicly disclose their locations or pathogen activities
• 91% of countries operating BSL-3 labs lack dual-use research oversight
• Roughly half of global facilities are located in the United States
• More than 300 documented lab leaks have occurred since 2001.